{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23800048",
  "DateCompleted": {
    "Year": "2013",
    "Month": "11",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "06",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1186/2047-783X-18-18"
    ],
    "Journal": {
      "ISSN": "2047-783X",
      "JournalIssue": {
        "Volume": "18",
        "Issue": "1",
        "PubDate": {
          "Year": "2013",
          "Month": "Jun",
          "Day": "24"
        }
      },
      "Title": "European journal of medical research",
      "ISOAbbreviation": "Eur J Med Res"
    },
    "ArticleTitle": "High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker.",
    "Pagination": {
      "StartPage": "18",
      "MedlinePgn": "18"
    },
    "Abstract": {
      "AbstractText": [
        "Human HIV-1 TAT interactive protein 2 (HTATIP2/TIP30) is an evolutionarily conserved gene that is expressed ubiquitously in human tissues and some tumor tissues. This protein has been found to be associated with some gynecological cancers; as such, this study aimed to investigate blood HTATIP2/TIP30 levels in patients with ovarian cancer.",
        "Twenty-three women with ovarian cancer and 18 patients with various non-cancerous gynecological complaints (for example, dysfunctional uterine bleeding, fibroids, and urinary incontinence) were included in the study. The pathological diagnosis of ovarian cancer was adenocarcinoma. HTATIP2/TIP30 concentration in the patients' blood samples was determined using ELISA kits.",
        "The HTATIP2/TIP30 level was significantly higher in the cancer group than in the control group (1.84 \u00b1 0.82 versus 0.57 \u00b1 0.13 ng/ml, mean \u00b1 SD).",
        "We demonstrated the potential role of HTATIP2/TIP30 in ovarian cancer for the first time, thereby enlightening future studies targeting HTATIP2/TIP30 in ovarian cancer treatment, diagnosis, and prevention."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Obstetrics and Gynecology, Ataturk University, Faculty of Medicine, Erzurum 25240, Turkey."
          }
        ],
        "LastName": "Kumtepe",
        "ForeName": "Yakup",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Halici",
        "ForeName": "Zekai",
        "Initials": "Z"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Sengul",
        "ForeName": "Ozlem",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kunak",
        "ForeName": "Celalettin Semih",
        "Initials": "CS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bayir",
        "ForeName": "Yasin",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kilic",
        "ForeName": "Nergiz",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cadirci",
        "ForeName": "Elif",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pulur",
        "ForeName": "Alparslan",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bayraktutan",
        "ForeName": "Zafer",
        "Initials": "Z"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Eur J Med Res",
    "NlmUniqueID": "9517857",
    "ISSNLinking": "0949-2321"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Transcription Factors"
    },
    {
      "RegistryNumber": "EC 2.3.1.-",
      "NameOfSubstance": "Acetyltransferases"
    },
    {
      "RegistryNumber": "EC 2.3.1.48",
      "NameOfSubstance": "HTATIP2 protein, human"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Acetyltransferases"
    },
    {
      "QualifierName": [
        "blood",
        "diagnosis",
        "pathology"
      ],
      "DescriptorName": "Adenocarcinoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diagnosis, Differential"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "blood",
        "diagnosis",
        "pathology"
      ],
      "DescriptorName": "Genital Diseases, Female"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology",
        "virology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathogenicity"
      ],
      "DescriptorName": "HIV-1"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Targeted Therapy"
    },
    {
      "QualifierName": [
        "blood",
        "diagnosis",
        "pathology"
      ],
      "DescriptorName": "Ovarian Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Transcription Factors"
    }
  ]
}